India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Why and when to vaccinate a child? Vaccination is an effective achievement of medical science. Vaccination is done to protect the body from any possible disease that may occur in the future. Vaccination protects against possible future diseases. Vaccination is done by injecting the dead or weakened bacteria of the related disease into the human body. White blood cells are activated to produce disease-fighting antibodies. Especially the immune system of newborns is very weak. So they can suffer from even minor diseases. Therefore, they are vaccinated against some diseases that may occur. In particular, to keep children healthy, to protect them from disability, and to prevent them from getting serious diseases, they should complete the set amount of vaccinations. Age-wise vaccination schedule has also been prepared for newborns. In this case, first-time parents should know which vaccines are available for newborns in Nepal and when to administer them. Why wear it? After the child is...